On Antimicrobial Resistance, It’s Now or Never
The human and economic toll of rising antimicrobial resistance is set to spiral out of control: left unchecked, drug-resistant infections could claim ten million lives each year by 2050, and cost global GDP a cumulative $100 trillion. We can avert this bleak future only if we launch an effective response immediately.
LONDON – We often take it for granted that any infection we encounter can be cured, and that all-powerful modern medicine will do precisely what it is supposed to do.